Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
277 participants
OBSERVATIONAL
2016-09-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders
NCT03826888
Blood Spot Self-administered Test and Assay
NCT03840824
Anti-Mullerian Hormone - At My Home
NCT04784325
The Effect of Birth Control Methods on Anti-Mullerian Hormone (AMH) Levels
NCT01308931
Assessing Ovarian Function During Prolonged Implant Use
NCT03058978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Access AMH Assay
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular menstrual cycle
* Both ovaries present
Exclusion Criteria
* Confirmed ovarian endometrioma
* Ovarian surgery prior to enrollment
* Being treated for cancer
* Hormonal contraceptive use prior to enrollment
* Currently pregnant
21 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Coulter, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fred Siebert
Role: STUDY_DIRECTOR
Beckman Coulter
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BRI
Phoenix, Arizona, United States
Stanford
Palo Alto, California, United States
FSMG
San Diego, California, United States
RAD
Newark, Delaware, United States
WRMG
Clearwater, Florida, United States
Vios Fertility
Swansea, Illinois, United States
BIVF
Waltham, Massachusetts, United States
Mainline Fertility
Bryn Mawr, Pennsylvania, United States
Univ Pennsylvania
Philadelphia, Pennsylvania, United States
CARE
Dallas, Texas, United States
CORM
Webster, Texas, United States
PNWF
Seattle, Washington, United States
Clinique Ovo
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMH 2.7.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.